Sutro Biopharma Inc. (NASDAQ: STRO) has announced that it will present preliminary data from its current dose-expansion cohort of the first phase STRO-002 study in ovarian cancer patients at a KPL virtual event. Phase 1 dose expansion group comprises ovarian cancer patients  The first phase dose-expansion cohort comprises advanced ovarian cancer patients with progressing illness who […]

Post-operative cognitive decline (POCD) is a state in which new cognitive impairments arise in patients after a surgical procedure. It can occur in patients following surgeries to repair a hip fracture, coronary artery bypass, or other procedures. People who suffer from POCD can develop difficulty remembering things and performing daily tasks, and may possibly end […]

Dr. Michael Singer, CSO at Cartesian Therapeutics, details why RNA has advantages over other cell therapies, the company’s three RNA trials, and the therapeutic benefit of multiple modifications.